Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity
Jn. Martin et al., Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity, AM J OBST G, 180(6), 1999, pp. 1407-1412
OBJECTIVE: This study was undertaken to investigate the utility of an admis
sion battery of findings and laboratory data in the discrimination of patie
nts with severe preeclampsia with or without HELLP (hemolysis, elevated liv
er enzyme levels, and low platelet count) syndrome at high risk for develop
ment of significant maternal morbidity.
STUDY DESIGN: The clinical and laboratory findings at hospital admission fo
r 970 patients with severe preeclampsia with or without HELLP syndrome were
studied retrospectively to develop parameters associated with low, moderat
e, and high risks for the subsequent development of significant maternal mo
rbidity involving the hematologic and coagulation, cardiopulmonary, and hep
atorenal systems.
RESULTS: Nausea and vomiting and epigastric pain are independent risk facto
rs for complicated severe preeclampsia. Results of a panel of tests with va
lues including lactate dehydrogenase level >1400 IU/L, aspartate aminotrans
ferase level >150 IU/L, alanine aminotransferase level >100 IU/L, uric acid
level 17.8 mg/dL, serum creatinine level >1.0 mg/dL, and 4+ urinary protei
n by dipstick can be used to discriminate the patient at high risk for sign
ificant maternal morbidity. Concentrations of lactate dehydrogenase, aspart
ate aminotransferase, and uric acid above these cut points have the stronge
st predictive value and are risk additive with worsening thrombocytopenia.
CONCLUSION: The presence of nausea and vomiting, epigastric pain, or both i
n association with admission laboratory values that are in excess of the cu
toffs for lactate dehydrogenase, aspartate aminotransferase, and uric acid
concentrations or for all 6 tests is predictive of high risk of morbidity f
or the patient with severe preeclampsia. These factors are independent of a
nd additive with the rising maternal risk associated with decreasing platel
et count.